(NYSE: AVNS) Avanos Medical's forecast annual revenue growth rate of 0.63% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.07%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.8%.
Avanos Medical's revenue in 2025 is $689,200,000.On average, 2 Wall Street analysts forecast AVNS's revenue for 2025 to be $31,323,822,293, with the lowest AVNS revenue forecast at $31,214,686,500, and the highest AVNS revenue forecast at $31,432,958,086. On average, 2 Wall Street analysts forecast AVNS's revenue for 2026 to be $32,248,701,893, with the lowest AVNS revenue forecast at $32,218,180,866, and the highest AVNS revenue forecast at $32,279,222,920.
In 2027, AVNS is forecast to generate $33,246,415,761 in revenue, with the lowest revenue forecast at $33,203,177,640 and the highest revenue forecast at $33,289,653,883.